The Europe Medical Radiation Shielding Market would witness market growth of 6.0% CAGR during the forecast period (2023-2030).
Tailored shielding solutions will be created, improving their efficiency and adaptability to certain medical conditions. This is made possible by precision manufacturing methods and computer simulations. Additionally, artificial intelligence and machine learning will revolutionize dose optimization and individualized shielding design, significantly enhancing patient and healthcare provider safety. The market will witness a seismic change as the sector adopts these technological transformative shifts, fostering safer and more effective medical procedures.
Medical radiation involves exposure to patients and healthcare professionals from radiography systems like X-rays, MRI, nuclear imaging, and other radiography systems. Hospitals, dentists, ambulatory surgical centers, and diagnostics facilities are the primary users of all these systems. Medical radiation can lead to several negative side effects, including acute radiation sickness, a higher risk of developing cancer, eye damage, chromosome aberration, skin injury, and nervous system damage. People can be protected from the negative consequences of ionizing radiation exposure via medical radiation shielding. This ionizing radiation damages living tissues at minuscule scales, which poses a serious health risk. Ionizing radiation causes severe tissue damage, sickness, and skin burns.
According to National Library of Medicine, there were 1.9 million cancer-related fatalities and 4 million new instances of cancer (except for non-melanoma skin cancer) in the Europe region in 2020. The most prevalent malignancies were prostate (470,000), lung (480,000), colorectal (520,000), and breast (530,000 occurrences in women). The demand for digital devices, including clinical efficiency tools, monitoring devices, and health analytics tools, is increasing as such types of equipment are considered essential to enhance clinical outcomes and patient experience across the region. All these elements are predicted to support the growth of the market in Europe region.
The Germany market dominated the Europe Medical Radiation Shielding Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $140.4 million by 2030. The UK market is anticipated to grow at a CAGR of 5.1% during (2023 - 2030). Additionally, The France market would witness a CAGR of 6.8% during (2023 - 2030).
Based on Product, the market is segmented into MRI Shielding Products, High-Density Concrete Blocks, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls & Plywood, Lead Bricks, X-ray Rooms, Lead Curtains, Lead Acrylic, Lead Sheet, and Others. Based on Solution, the market is segmented into Diagnostic Shielding (MRI, CT Scanners, X-ray, and Nuclear Imaging), and Radiation Therapy Shielding (Linear Accelerators, Multimodality, Cyclotron, Brachytherapy, and Proton Therapy). Based on End User, the market is segmented into Hospitals, Clinics & ASCs, and Diagnostic Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Medical Radiation Shielding Market is Projected to reach USD 2.1 Billion by 2030, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Mirion Technologies, Inc., ETS- Lindgren, Inc. (ESCO Technologies, Inc.), Nelco Worldwide, Gaven Industries, Inc. (3RC), MarShield (Marswell Group of companies), Ray-Bar Engineering Corp, Amray Group Ltd., A&L Shielding, Radiation Protection Products, Inc., and Global Partners in Shielding, Inc.
By Product
By Solution
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
